Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Trump administration cuts hit biotech sector, causing job losses and discouraging investments.
The Trump administration's cuts to federal health agencies have deepened the biotech sector's slump.
Mass firings at the FDA and funding freezes from the NIH increase uncertainty for small and mid-cap biotech firms, impacting drug approvals and discouraging investment.
The S&P Biotech ETF index hit an 18-month low, down 20% this year, with concerns over the FDA's ability to fulfill its role.
3 Articles
Los recortes de la administración Trump afectaron al sector biotecnológico, causando pérdidas de puestos de trabajo y desincentivando las inversiones.